Press Release

Growing Incidences of Skin Diseases Catalyzing the Growth of the Global Skin Microbiome Modulators Market

Rising incidences of skin diseases such dermatitis, psoriasis, eczema, acne vulgaris, allergy, wounds, and anti-ageing diseases, surging investment in the field of skin microbiome research, and burgeoning number of collaborations among cosmeceutical companies are projected to place a positive impact on the growth of Global skin microbiome modulators market in the forecast period. Besides this, expansion in the product portfolio of probiotic-and prebiotic-infused products for skincare of the giant cosmetic companies is expected to fuel the demand for skin microbiome modulators in the forthcoming years.

According to MarkNtel Advisors’ research report titled “Global Skin Microbiome Modulators Market Analysis, 2020”, the Global Skin Microbiome Modulators market is anticipated to grow at a CAGR of around 15% during 2020-25. Based on Product Type, Probiotic acquired the considerable market share in 2019. Probiotics are live bacteria and yeasts that provide health benefits when consumed as they improve and restore the gut flora and are helpful in chronic intestinal disorders. The escalating demand for probiotic products among customers due to its natural approach to maintain or restore human health and to boost the immunotherapy treatments, coupled with rising number of companies’ product portfolios within probiotics are key factors driving the growth of the market in the near future.

“Global Skin Microbiome Modulators Market Analysis, 2020” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and growth opportunities available for Skin Microbiome Modulators providers across the globe. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on 16 parameters. This will help companies in the formulation of Go to Market Strategies and identifying the blue ocean for its offerings.      

North America Acquired the Majority Share

North America acquired the majority share in the market in 2019. US accounted for the highest market share in the North America market owing to the factors such as rising skin diseases such as acne vulgaris among the people, booming ageing population, coupled with the presence of major market players in the country. Acne is the most common skin condition in the United States, affecting up to 50 million Americans annually. Moreover, surging use of microbiome by the cosmetic companies and escalating investment in R&D for microbiomes are anticipated to upsurge the growth of the Skin Microbiome Modulators Market in the forthcoming period as stated in MarkNtel Advisors’ research report “Global Skin Microbiome Modulators Market Analysis, 2020”. 

According to MarkNtel Advisors, the key players with a considerable market share in the Global Skin Microbiome Modulators market are Azitra Inc., Colgate- Palmolive Company, Evelo Biosciences Inc., GALLINEE, Glowbiotics Inc., Johnson & Johnson Services, L’Oreal SA, Matrisys Bioscience, Quorum Innovations, Revlon, Siolta Therapeutics, The Estee Lauder Companies Inc., Tula Life Inc., Unilever, and Yakult Honsha Co. Ltd.

Market Segmentation:

1. By Product Type (Probiotics, Prebiotics, Drugs)
2. By Application (Skincare, Haircare, Others)
3. By Distribution (Drug Stores, Hypermarkets & Supermarkets, Specialty Stores, Online Channels, Others)
4. By Region (North America, South America, Europe, Asia-Pacific, Middle East & Africa)
5. By Country (US, Canada, Brazil, Spain, UK, Germany, France, Italy, China, Japan, South Korea, Australia, India),
6. By Company (Azitra Inc., Colgate- Palmolive Company, Evelo Biosciences Inc., GALLINEE, Glowbiotics Inc., Johnson & Johnson Services, L’Oreal SA, Matrisys Bioscience, Quorum Innovations, Revlon, Siolta Therapeutics, The Estee Lauder Companies Inc., Tula Life Inc., Unilever, Yakult Honsha Co. Ltd etc.)

Key questions answered in the study:

1. What are the current and future trends of the Skin Microbiome Modulators industry?
2. How the industry has been evolving in terms of end-user demand and application areas?
3. How the competition has been shaping across the countries followed by their comparative factorial indexing?
4. What are the key growth drivers and challenges for the Skin Microbiome Modulators industry?
5. What is the customer orientation, purchase behavior, and expectations from the Skin Microbiome Modulators firms across various regions?